PNC FINANCIAL SERVICES GROUP, INC. - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 66 filers reported holding ONCOCYTE CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q2 2023$2,300
-35.0%
10,0000.0%0.00%
Q1 2023$3,540
+10.3%
10,0000.0%0.00%
Q4 2022$3,210
-54.1%
10,0000.0%0.00%
Q3 2022$7,000
-22.2%
10,0000.0%0.00%
Q2 2022$9,000
-40.0%
10,0000.0%0.00%
Q1 2022$15,000
+1400.0%
10,000
+3211.3%
0.00%
Q3 2021$1,000302
+2057.1%
0.00%
Q2 2020$0140.0%0.00%
Q1 2020$0140.0%0.00%
Q4 2019$0140.0%0.00%
Q3 2019$0140.0%0.00%
Q2 2019$0140.0%0.00%
Q1 2019$0140.0%0.00%
Q4 2018$0140.0%0.00%
Q3 2018$0140.0%0.00%
Q2 2018$0140.0%0.00%
Q1 2018$0140.0%0.00%
Q4 2017$0140.0%0.00%
Q3 2017$0140.0%0.00%
Q2 2017$0
-100.0%
14
-99.7%
0.00%
Q1 2017$24,000
-14.3%
4,0140.0%0.00%
Q4 2016$28,000
+40.0%
4,0140.0%0.00%
Q3 2016$20,000
+42.9%
4,0140.0%0.00%
Q2 2016$14,000
-22.2%
4,0140.0%0.00%
Q1 2016$18,0004,0140.00%
Other shareholders
ONCOCYTE CORP shareholders Q3 2022
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 23,353,697$17,048,0001.30%
AWM Investment Company, Inc. 7,746,557$5,655,0000.86%
PURA VIDA INVESTMENTS, LLC 18,056,274$13,181,0000.76%
Defender Capital, LLC. 2,551,980$1,883,0000.74%
Penbrook Management LLC 563,350$411,0000.35%
ACT CAPITAL MANAGEMENT, LLC 330,000$241,0000.33%
CALIBER WEALTH MANAGEMENT, LLC 75,120$55,0000.04%
Fort Sheridan Advisors LLC 135,000$99,0000.03%
Orbimed Advisors 1,882,768$1,374,0000.03%
WEALTH EFFECTS LLC 51,000$37,0000.02%
View complete list of ONCOCYTE CORP shareholders